Medicinal Cannabis Industry Approach

The medicinal cannabis industry currently consists of either medical marijuana producers or the traditional pharmaceutical approach. The pharmaceutical approach traditionally involves the study of individual cannabinoids as target molecules for drug discovery. This approach has generally proven to be both costly and time consuming. The rapidly growing medical marijuana industry on the other hand commonly develops inconsistent products as pharmaceutical grade quality assurance/quality control (QA/QC) is not present. Additionally, these products lack solid scientific proof of effectiveness.

Veritas’ Approach

Veritas innovative research and development approach aims to solve the critical need for real science to support claims surrounding medical marijuana. Our scientific approach combined with our strategic alliances intends to effectively address the concerns over the medical industry’s varied output in content and quality, potency and efficacy.

Veritas has developed a three-pronged approach to research and development:

  • First, we aim to chemically profile different marijuana cultivars.
  • Subsequently, those same cultivars will pharmacologically be profiled in the search for disease-specific strains.
  • Finally, we aim to perform clinical trials to establish the clinical utility of each cultivar.

This unique approach has the advantage of being low cost, and allows for faster market entry, providing doctors and patients with conclusive scientific evidence to recommend and use medical marijuana with confidence. Similarly, the presence of conclusive scientific evidence could potentially develop the platform allowing coverage through medical insurance providers.

I think we are quite unique in the industry, in that we are more concerned about the actual spectrum of cannabinoids, in terms of a biological effect. Leading Veritas to patent and protect a results proven strain, making us distinct in the industry.

Dr. Lui Franciosi


Target Disease Conditions

Clinical trials will focus on demonstrating the clinical utility of the following disease conditions:

  • Chronic Pain (e.g. cancer pain)
  • Nausea & Vomiting
  • Muscle Spasms
  • Epilepsy
  • Post-Traumatic Stress Disorder (PTSD)

The Veritas Newsletter

Enter your email to receive news alerts and updates from Veritas Pharma.

You have Successfully Subscribed!